Protalix BioTherapeutics
PLX
#8264
Rank
A$0.31 B
Marketcap
$4.23
Share price
1.13%
Change (1 day)
81.75%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -A$11.83 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$45.66 Million. In 2023 the company made an earning of A$18.49 Million, an increase over its 2022 earnings that were of -A$18.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$11.83 Million-163.9%
2023 A$18.49 M-199.05%
2022 -A$18.68 Million-40.38%
2021 -A$31.33 Million-732.31%
2020 A$4.95 M-130.53%
2019 -A$16.23 Million189.85%
2018 -A$5.6 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$29.14 Million-32.37%
2015 -A$43.08 Million10.11%
2014 -A$39.13 Million-7.59%
2013 -A$42.34 Million
2011 -A$49.03 Million-19.39%
2010 -A$60.82 Million20.87%
2009 -A$50.32 Million32.26%
2008 -A$38.05 Million-5.46%
2007 -A$40.24 Million
2004 -A$0.27 Million12.35%
2003 -A$0.24 Million-11.1%
2002 -A$0.27 Million-57.03%
2001 -A$0.61 Million1.03%
2000 -A$0.61 Million-53.22%
1999 -A$1.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.11 Billion 781.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.03 B-8,564.81%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.92 B-89,594.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.66 B-5,513.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel